Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
This study has been completed.
Study NCT01451541   Information provided by Sunovion

First Received on October 11, 2011.   Last Updated on January 3, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Perennial Allergic Rhinitis
PAR
Additional conditions recognized in this trial
Rhinitis
Rhinitis, Allergic, Perennial
More general conditions related to this trial
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Ciclesonide nasal aerosol 37 mcg
ciclesonide nasal aerosol 74 mcg
Placebo
Additional drug interventions recognized in this trial
Ciclesonide
More general drug interventions related to this trial
Anti-Allergic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Sunovion


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services